Twenty-two years devoted to a single specialty.
Results that look natural, and remain so over time.
The thickness of the fold, its starting point, and the way it tapers are all determined by the patient's individual anatomy and overall facial proportions. We begin with a careful examination of the bone structure and the soft tissue around the eye, and design a result that suits the patient's features and continues to hold its shape over time.
"Across ptosis correction, epicanthoplasty, and aging, male, and lower blepharoplasty,
the measure of a successful result is the same: it should look natural, and it should last."
We recommend the approach best suited to your anatomy and goals.
Adjustment of the levator muscle to create a clearly defined fold, secured with dynamic fixation.
Medial, lateral, and lower epicanthoplasty to open a narrow eye shape while preserving overall balance.
Monolid ptosis correction or a hidden-fold technique for a refined result without an evident crease.
Upper and lower blepharoplasty, combined with brow lift when indicated, to address heavy lids and crow's feet.
Fat repositioning with septal reinforcement to address dark circles while preserving the natural under-eye fold.
Four principles that guide every procedure.
Every procedure is performed by Director Choi Dong-Il, from initial design through final closure.
Each fold is designed within the context of the patient's overall facial proportions.
Twenty-two years dedicated to a single specialty have produced a depth of clinical experience in eyelid anatomy and outcomes.
Scheduled visits at one week, one month, and six months allow us to monitor healing and refine the final result.
From your first consultation through long-term follow-up.
Online, phone, or KakaoTalk
Facial assessment and design
Performed by the director
Personalized aftercare plan
1 week · 1 month · 6 months
All photographs shown are taken six months after surgery.
Common questions patients raise during consultation.
Every inquiry is reviewed personally by Director Choi Dong-Il.